Accession Number: | 0001567619-20-006345 |
Date: | 2020-03-11 |
Issuer: | APTOSE BIOSCIENCES INC. (APTO) |
Original Submission Date: | 2020-03-13 |
VINCENT MARK D.
C/O APTOSE BIOSCIENCES INC.
251 CONSUMERS ROAD, SUITE 1105
TORONTO, A6 M2J 4R3
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
DIRECTOR OPTION GRANT | 7.13 | 2020-03-11 | deemed execution date | A | 50,000 (a) | 2021-03-11 | 2030-03-10 | common shares 50,000 | $7.13 | 50,000 | direct |
ID | footnote |
---|---|
f1 | converted from canadian exercise price of c$9.80 using an exchange rate of 1.3745. |